AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease.
@AASLDFoundation@AASLDPresident
The #TLM26 Poster Hall is where research meets conversation. Attendees have the opportunity to explore the latest findings, connect directly with poster authors, and dive deeper into the research shaping liver care.
Today’s presentations spanned topics from MASLD, molecular
Turn your floor exploration into prizes and let the Liver Quest begin! 🔍
Every day from Thursday through Sunday at #TLM26, follow the clues, find the three Liver Quest QR codes, and scan them in the #TLM26 mobile app by 7 PM MT for a chance to win that day’s prize.
🏆 Keep
🚨 BREAKING RESEARCH NEWS: Phase III Clinical Trial Results Published in @HEP_Journal
AASLD is proud to announce the publication of positive Phase III results from the ELSPIRE trial in HEPATOLOGY, AASLD’s flagship journal.
The study evaluated elafibranor, a PPAR-α/δ agonist,
#TLM26 if officially underway! 🙌
It’s great to see the hepatology community back together to learn, connect, and advance liver disease research and care. Let’s get this meeting started!
